Maynard Um
-
-
-
-
-
-
-
BioCardia receives Japanese patent allowance for Heart3D imaging software
-
-
-
-
-
-
-
BioCardia holds preliminary consultation with Japan drug agency on heart therapy
-
-
-
-
-
-
-
BioCardia (BCDA) Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Trial
-
-
-
-
-
-
-
BioCardia (BCDA) Misses Q3 EPS by 61c
-
-
-
-
-
-
-
BioCardia, Inc. (BCDA) Tops Q2 EPS by 12c
-
-
418,485 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

